Why is Cracker Barrel reverting to old logo?
How did Trump’s tariffs impact India’s exports?
What to expect from Nvidia’s upcoming earnings?
Why is Lisa Cook suing President Trump?
How did SpaceX’s Starship 10th test flight perform?
What drove MongoDB’s recent stock surge?
Why are global postal services stopping US deliveries?
FDA Extends Decision Date On Regenxbio's Gene Therapy Into Next Year
benzinga.com/news/fda/25/08/47214137/fda-extends-decision-date-on-regenxbios-gene-therapy-into-next-year
The U.S. Food and Drug Administration (FDA) on Monday extended its review timeline for REGENXBIO Inc.’s (NASDAQ:RGNX) Biologics License Application (BLA) for clemidsogene lanparvovec (RGX-121) for Mucopolysaccharidosis II (MPS II), also known as Hunter syndrome.
The Prescription Drug…
This story appeared on benzinga.com, 2025-08-19 16:01:09.